semaglutide addiction treatment Ozempic, Mounjaro may help with alcohol and opioid addiction, study finds : Shots GLP-1 medications: The next big

Initial treatment withacetazolamide was discontinued due to intolerance.Exenatide was subsequently initiated, leading to early improvement in headache frequency and diplopia, independent of weight loss

Theres no single best GLP-1 for weight loss but Wegovy and Mounjaro currently lead in clinical results

A weekly dose of semaglutide, the key ingredient in blockbuster medications Ozempic and Wegovy, helped seven out of 10 patients newly diagnosed with type 1 diabetes stop taking insulin after three to six months in a small study.

But if the prevention trials confirm what the observational data suggests, this class of drugs could change dementia care more than anything we've seen in decades

Read Dave's full perspective in his latest newsletter

Eli Lilly announced positive topline results from the ATTAIN-2 Phase 3 trial of orforglipron, an oral GLP-1 receptor agonist for obesity and type 2 diabetes.